Bacillus coagulans Unique IS2 improves stool characteristics in healthy adults with infrequent bowel movements: a randomized, double-blind, placebo-controlled trial
Beneficial Microbes · 2025
DOI: 10.1163/18762891-bja00072 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Beneficial Microbes, 2025. Verfasst von A LeMoire und 10 weiteren Autor:innen. Beteiligte Einrichtung: 419393Nutrasource Pharmaceutical and Nutraceutical Services, Inc. Guelph, ON, Canada. Hauptthemen laut MEDLINE: Feces, Bacillus coagulans, Probiotics, Defecation. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PepsiCo.
Abstract (Originalsprache)
Digestive health issues, including irregular bowel movements (BM) and gastrointestinal (GI) symptoms, affect millions of people in the United States and are associated with higher risks of various diseases. This randomized, double-blind, placebo-controlled study investigated the potential of Bacillus coagulans Unique IS2 to improve stool characteristics and reduce GI symptoms. Following a 2-week run-in, 144 healthy adults were randomized in a 1:1 ratio to either B. coagulans Unique IS2 (2 billion colony forming units/day) or placebo for 4 weeks. Participants were included if they had an average weekly complete spontaneous bowel movement (SBM) of ≥3.0 and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 419393Nutrasource Pharmaceutical and Nutraceutical Services, Inc. Guelph, ON, Canada.
- PepsiCo Inc., Old Post Office, 433 W Van Buren St. Chicago, IL 60607, USA.
- Apex Trials, Guelph, ON, Canada.
ORCID-Profile: A LeMoire, R Replogle, L Shinn, L Lin, S-A Girard, S Recker
Förderung
- PepsiCo
Zitieren
APA
LeMoire, A., Replogle, R., Shinn, L., Kamil, A., Lin, L., Kuttenkeuler, A. P., Baisley, J., Wang, J., Girard, S. A., Recker, S., & Bier, A. (2025). Bacillus coagulans Unique IS2 improves stool characteristics in healthy adults with infrequent bowel movements: a randomized, double-blind, placebo-controlled trial. Beneficial Microbes. https://doi.org/10.1163/18762891-bja00072
Vancouver
LeMoire A, Replogle R, Shinn L, Kamil A, Lin L, Kuttenkeuler AP, et al. Bacillus coagulans Unique IS2 improves stool characteristics in healthy adults with infrequent bowel movements: a randomized, double-blind, placebo-controlled trial. Beneficial Microbes. 2025. doi:10.1163/18762891-bja00072
BibTeX
@article{LeMoire2025,
author = {LeMoire, A and Replogle, R and Shinn, L and Kamil, A and Lin, L and Kuttenkeuler, A P and Baisley, J and Wang, J and Girard, S-A and Recker, S and Bier, A},
title = {Bacillus coagulans Unique IS2 improves stool characteristics in healthy adults with infrequent bowel movements: a randomized, double-blind, placebo-controlled trial},
journal = {Beneficial Microbes},
year = {2025},
doi = {10.1163/18762891-bja00072}
}
EUVIMED